US Stock MarketDetailed Quotes

XFOWW X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B

Watchlist
  • 0.012
  • 0.0000.00%
15min DelayTrading Jul 31 16:00 ET
0Market Cap0.00P/E (TTM)

About X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B Company

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

Company Profile

SymbolXFOWW
Company NameX4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B
Listing DateNov 16, 2017
Founded2010
CEODr. Paula S. Ragan, PhD
MarketPink Market
Employees93
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address61 North Beacon Street,4th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02134
Phone1-857-529-8300
Websitehttp://www.x4pharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paula S. Ragan, PhD
  • Director, President and Chief Executive Officer
  • 2.04M
  • Arthur Taveras
  • Chief Scientific Officer
  • --
  • Dr. Mary DiBiase, PhD
  • Chief Operating Officer
  • --
  • Mark Baldy
  • Chief Commercial Officer
  • --
  • Adam S. Mostafa
  • Chief Financial Officer, Principal Accounting Officer, Treasurer and Corporate Secretary
  • 1.15M
  • Christophe Arbet-Engels
  • Chief Medical Officer
  • 1.64M
  • Michael Stephen Wyzga
  • Chairman of the Board
  • 199.34K
  • Dr. Murray W. Stewart, M.D.
  • Director
  • 90.08K
  • Dr. Gary J. Bridger, PhD
  • Director
  • 147.05K
  • Francoise de Craecker
  • Independent Director
  • 152.05K
  • Alison F. Lawton
  • Independent Director
  • 154.55K
  • William E. Aliski
  • Independent Director
  • 165.05K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 166.05K
  • Robert Keith Woods
  • Independent Director
  • 91.83K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg